As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help ...

Triumphs of COVID-19 included rapid vaccine development and scientific collaboration. But the tragedies were numerous.

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

New research suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development, an ...

Department of Health and Human Services Secretary Robert F. Kennedy Jr. paused a $240 million contract to create a new coronavirus vaccine.

This covers Novavax’s stand-alone adjuvanted Covid-19 vaccine ... and improving access to life-saving vaccines.” Investors will also note that Novax reported diluted earnings per share ...

You're watching Coronavirus in Context. I'm Dr. John Whyte, chief medical officer at WebMD. There's a lot of talk about vaccines. Some folks are saying it's going to be available by the fall.

Everything you need to know about getting a Covid-19 vaccination ... there are vaccination updates in your state: The Plan Your Vaccine page will be updated as new information is released from ...

The COVID-19 pandemic has triggered an unprecedented mobilization of resources to find vaccines and therapeutics to treat and prevent infection with SARS-CoV-2. mRNA technology was quickly adopted ...